BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12218045)

  • 1. Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent.
    Zhu T; Ling L; Lobie PE
    J Biol Chem; 2002 Nov; 277(47):45592-603. PubMed ID: 12218045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
    Carter-Su C; Rui L; Stofega MR
    Recent Prog Horm Res; 2000; 55():293-311. PubMed ID: 11036942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional association between Arf and RalA in active phospholipase D complex.
    Luo JQ; Liu X; Frankel P; Rotunda T; Ramos M; Flom J; Jiang H; Feig LA; Morris AJ; Kahn RA; Foster DA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3632-7. PubMed ID: 9520417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
    Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
    Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RalA and PLD1 promote lipid droplet growth in response to nutrient withdrawal.
    Hussain SS; Tran TM; Ware TB; Luse MA; Prevost CT; Ferguson AN; Kashatus JA; Hsu KL; Kashatus DF
    Cell Rep; 2021 Jul; 36(4):109451. PubMed ID: 34320341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity.
    Frankel P; Aronheim A; Kavanagh E; Balda MS; Matter K; Bunney TD; Marshall CJ
    EMBO J; 2005 Jan; 24(1):54-62. PubMed ID: 15592429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cargo exocytosis by a Reps1-Ralbp1-RalA module.
    Wang S; Chen X; Crisman L; Dou X; Winborn CS; Wan C; Puscher H; Yin Q; Kennedy MJ; Shen J
    Sci Adv; 2023 Feb; 9(8):eade2540. PubMed ID: 36812304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival.
    Chien Y; White MA
    EMBO Rep; 2003 Aug; 4(8):800-6. PubMed ID: 12856001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of AMP-activated protein kinase in cancer cell lines is mediated through c-Src activation.
    Mizrachy-Schwartz S; Cohen N; Klein S; Kravchenko-Balasha N; Levitzki A
    J Biol Chem; 2011 Apr; 286(17):15268-77. PubMed ID: 21245141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes.
    Andrei C; Margiocco P; Poggi A; Lotti LV; Torrisi MR; Rubartelli A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9745-50. PubMed ID: 15192144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WIP1 is a novel specific target for growth hormone action.
    Apaydin T; Zonis S; Zhou C; Valencia CW; Barrett R; Strous GJ; Mol JA; Chesnokova V; Melmed S
    iScience; 2023 Nov; 26(11):108117. PubMed ID: 37876819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH-dependent growth of experimentally induced carcinomas in vivo.
    Marker PC; Unterberger CJ; Swanson SM
    Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36826838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients.
    Zhao Y; Ji Z; Li J; Zhang S; Wu C; Zhang R; Guo Z
    Front Oncol; 2022; 12():917313. PubMed ID: 36016614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.
    Dong X; Su L; Patti ME
    Curr Diab Rep; 2022 Oct; 22(10):511-524. PubMed ID: 36001217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and Treatment of Growth Delay in Noonan Syndrome.
    Rodríguez F; Gaete X; Cassorla F
    Front Endocrinol (Lausanne); 2021; 12():691240. PubMed ID: 34149626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.
    Strous GJ; Almeida ADS; Putters J; Schantl J; Sedek M; Slotman JA; Nespital T; Hassink GC; Mol JA
    Front Endocrinol (Lausanne); 2020; 11():597573. PubMed ID: 33312162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of growth hormone on insulin signaling.
    Sharma R; Kopchick JJ; Puri V; Sharma VM
    Mol Cell Endocrinol; 2020 Dec; 518():111038. PubMed ID: 32966863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical and novel GH receptor signaling pathways.
    Frank SJ
    Mol Cell Endocrinol; 2020 Dec; 518():110999. PubMed ID: 32835785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of growth hormone on adipose tissue: old observations, new mechanisms.
    Kopchick JJ; Berryman DE; Puri V; Lee KY; Jorgensen JOL
    Nat Rev Endocrinol; 2020 Mar; 16(3):135-146. PubMed ID: 31780780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.
    Dehkhoda F; Lee CMM; Medina J; Brooks AJ
    Front Endocrinol (Lausanne); 2018; 9():35. PubMed ID: 29487568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.